All Curated Mutation Sites in HPV 
Back to Mutation Home

 The Virus Mutation(VM) module provides researchers the annotations of reported pathogenic mutations in HPV related to human diseases. The curated VM information includes mutation site, mutation level, virus gene/protein/region, virus-associated disease, genotype/subtype, literature evidence, etc.


Browse Data by Virus Gene/Protein/Region, Disease OR Description
*Please select one option you are interested in, the page will be automatically redirected.
     
     

Click the button below to quickly view the viral genes/regions/protein for mutation

Show All
  
E1
  
E1^E4
  
E2
  
E5
  
E6
  
E7
  
L1
  
L2
  

Keyword: Uterine Cervical Neoplasms-30081093
ID PMID Mutation Gene/Protein/Region Encoding Gene/Protein Disease Description Detail
1 30081093 A143T
E2
E2
Uterine Cervical Neoplasms
G
C
L
View
2 30081093 A2926G
E2
E2
Uterine Cervical Neoplasms
G
C
L
View
3 30081093 A3362G
E2
E2
Uterine Cervical Neoplasms
G
C
L
View
4 30081093 C3159A
E2
E2
Uterine Cervical Neoplasms
G
C
L
View
5 30081093 C3377G
E2
E2
Uterine Cervical Neoplasms
G
C
L
View
6 30081093 C3410T
E2
E2
Uterine Cervical Neoplasms
G
C
L
View
7 30081093 G3182A
E2
E2
Uterine Cervical Neoplasms
G
C
L
View
8 30081093 N203D
E2
E2
Uterine Cervical Neoplasms
G
C
L
View
9 30081093 P208A
E2
E2
Uterine Cervical Neoplasms
G
C
L
View
10 30081093 P219S
E2
E2
Uterine Cervical Neoplasms
G
C
L
View
11 30081093 Q57Q
E2
E2
Uterine Cervical Neoplasms
G
C
L
View
12 30081093 T135K
E2
E2
Uterine Cervical Neoplasms
G
C
L
View
13 30081093 T3694A
E2
E2
Uterine Cervical Neoplasms
G
C
L
View
14 30081093 T3805G
E2
E2
Uterine Cervical Neoplasms
G
C
L
View
Contents
Description

The table shows all curated mutation sites of HPV in each literature

Table Description Column Note
D
The study mentioned a certain treatment method, such as drug resistance caused by mutations.
G
The study mentioned the virus genotype/subtype information.
R
The study mentioned the reference sequence used for comparison, or the original strain of the virus used for site-directed mutagenesis.
S
The study provided sequence information or accession numbers.
L
The study provided the geographic region/country of data origin.
C
The study provided clinical baseline information.
I
The study involved information related to immune.
T
The study involved host target genes.